Sedhai Yub Raj, Golamari Reshma, Timalsina Santosh, Basnyat Soney, Koirala Ajay, Asija Ankush, Choksi Tatvam, Kushwah Akanksha, Geovorgyan David, Dar Tawseef, Borikar Madhura, Ahangar Waseem, Alukal Joseph, Zia Subtain, Missri Jose
Department of Internal Medicine, Mercy Catholic Medical Center, Darby, Pennsylvania.
Department of Internal Medicine, Mercy Catholic Medical Center, Darby, Pennsylvania.
Am J Med Sci. 2017 Nov;354(5):462-466. doi: 10.1016/j.amjms.2017.05.010. Epub 2017 May 31.
Contrast-induced nephropathy (CIN) is a common complication after radiocontrast exposure.
A retrospective medical record review of 513 hospitalized patients who underwent cardiac catheterization from June-December 2014 was done, of which 38 patients with end-stage renal disease and 57 patients without preprocedural creatinine were excluded. Serum creatinine concentration before the procedure and each day for 3 days after the procedure was recorded. CIN was defined as an increase in serum creatinine concentration by ≥25% or ≥0.5mg/dL from the preprocedural value within 72hours of contrast exposure.
A total of 418 patients (mean age: 69.1 ± 13.8 years, 55% males) were included in the study. Mean incidence of CIN was 3.7% (n = 16). CIN accounted for longer duration of hospitalization, lengthier intensive care unit admission, requirement of hemodialysis and higher mortality. Incidence of CIN was higher in the presence of preexisting atrial fibrillation (AF), congestive heart failure (CHF) and chronic kidney disease (CKD). When tested by univariate analysis, incidence of CIN was 13.8% in the AF group (P < 0.001), 8.6% in CHF group (P < 0.01) and 8.9% in CKD group (P < 0.002), compared with 2.3%, 1.9% and 2.4% in the absence of preexisting AF, CHF and CKD, respectively. On further testing using multivariate logistic regression model using AF, CHF and CKD as independent variables, development of CIN was strongly associated with preexisting AF with an odds ratio of 4.11, 95% CI: 1.40-12.07, P = 0.01.
Identifying patients at risk is an important step in preventing CIN. Preexisting AF, independent of traditional risk factors, may increase the risk for CIN.
对比剂肾病(CIN)是放射造影剂暴露后的常见并发症。
对2014年6月至12月接受心脏导管插入术的513例住院患者进行回顾性病历审查,排除38例终末期肾病患者和57例术前无肌酐的患者。记录术前及术后3天每天的血清肌酐浓度。CIN定义为造影剂暴露后72小时内血清肌酐浓度较术前值升高≥25%或≥0.5mg/dL。
共纳入418例患者(平均年龄:69.1±13.8岁,55%为男性)。CIN的平均发生率为3.7%(n = 16)。CIN导致住院时间延长、重症监护病房住院时间延长、需要血液透析以及死亡率更高。存在既往心房颤动(AF)、充血性心力衰竭(CHF)和慢性肾脏病(CKD)时,CIN的发生率更高。单因素分析显示,AF组CIN发生率为13.8%(P < 0.001),CHF组为8.6%(P < 0.01),CKD组为8.9%(P < 0.002),而无既往AF、CHF和CKD时分别为2.3%、1.9%和2.4%。进一步使用以AF、CHF和CKD为自变量的多因素逻辑回归模型进行检验,CIN的发生与既往AF密切相关,比值比为4.11,95%可信区间:1.40 - 12.07,P = 0.01。
识别高危患者是预防CIN的重要一步。既往AF独立于传统危险因素,可能增加CIN风险。